表紙
市場調查報告書
商品編碼
1063711

先進的藥物輸送的全球市場:產業分析,趨勢,市場規模,至2027年的預測

Advanced Drug Delivery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

出版日期: | 出版商: Infinium Global Research (IGR) | 英文 100 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球先進的藥物輸送的市場規模在預測期間內預計以4.37%的年複合成長率成長。牽引市場的主要原因有慢性疾病增加和由於各種疾病的醫療費增加等。可是動脈硬化治療藥的副作用和政府的嚴格規則和法規將成為妨礙市場的要素。還有先進性的研究開發將帶給市場機會。

本報告提供全球先進的藥物輸送市場調查,市場預測和概要,市場的推動因素與阻礙因素的分析,COVID-19影響,各類型,各用途,各技術,各地區的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • 市場概況
  • 市場預測
  • 市場地區的亮點

第3章 全球先進的藥物輸送市場:概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • COVID-19對市場的影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • 各類型
    • 各用途
    • 各技術
    • 各地區
  • 市場價值鏈分析

第4章 先進的藥物輸送市場:宏觀指標分析

第5章 全球先進的藥物輸送市場:各類型

  • 口服
  • 注射型
  • 吸入/肺
  • 經皮
  • 電信業者型
  • 其他

第6章 全球先進的藥物輸送市場:各用途

  • 心血管疾病
  • 腫瘤
  • 泌尿系統
  • 糖尿病
  • 中樞神經系統
  • 眼科
  • 感染疾病
  • 其他

第7章 全球先進的藥物輸送市場:各技術

  • 前驅藥物
  • 植入和子宮內避孕器
  • 標靶藥物傳輸
  • 高分子藥物輸送
  • 其他

第8章 全球先進的藥物輸送市場(2021年∼2027年):各地區

  • 北美
    • 各類型
    • 各用途
    • 各技術
    • 各國
  • 歐洲
    • 各類型
    • 各用途
    • 各技術
    • 各國
  • 亞太地區
    • 各類型
    • 各用途
    • 各技術
    • 各國
  • 其他地區
    • 各類型
    • 各用途
    • 各技術
    • 各子區域

第9章 企業簡介和競爭情形

  • 競爭情形
  • 企業簡介
    • Pfizer Inc.
    • AstraZeneca
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • Amgen Inc.
    • Novartis AG
    • Baxter International
    • Bayer AG
    • Medtronic
    • Kindeva Drug Delivery L.P.
目錄
Product Code: HC08746

The report on the global advanced drug delivery market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global advanced drug delivery market to grow with a CAGR of 4.37% over the forecast period from 2021-2027. The study on advanced drug delivery market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on advanced drug delivery market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global advanced drug delivery market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global advanced drug delivery market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising prevalence of chronic diseases
  • Increasing healthcare expenditure due to various disease

2) Restraints

  • Side effects atherosclerosis drugs
  • Stringent government rules and regulations

3) Opportunities

  • Advanced research and development

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global advanced drug delivery market is segmented on the basis of type, application, and technology.

The Global Advanced Drug Delivery Market by Type

  • Oral Drug Delivery System
  • Injection-based Drug Delivery System
  • Inhalation/Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Transmucosal Drug Delivery System
  • Carrier-based Drug Delivery System
  • Other Types

The Global Advanced Drug Delivery Market by Application

  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • Central Nervous System
  • Ophthalmology
  • Infections
  • Other Applications

The Global Advanced Drug Delivery Market by Technology

  • Prodrug
  • Implants and Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Other Technologies

Company Profiles

The companies covered in the report include:

  • Pfizer Inc.
  • AstraZeneca
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Amgen Inc.
  • Novartis AG
  • Baxter International
  • Bayer AG
  • Medtronic
  • Kindeva Drug Delivery L.P.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the advanced drug delivery market.

2. Complete coverage of all the segments in the advanced drug delivery market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global advanced drug delivery market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Advanced Drug Delivery Market Highlights
  • 2.2. Advanced Drug Delivery Market Projection
  • 2.3. Advanced Drug Delivery Market Regional Highlights

3. Global Advanced Drug Delivery Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Advanced Drug Delivery Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Type
    • 3.5.2. IGR-Growth Matrix Analysis by Application
    • 3.5.3. IGR-Growth Matrix Analysis by Technology
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Advanced Drug Delivery Market

4. Advanced Drug Delivery Market Macro Indicator Analysis

5. Global Advanced Drug Delivery Market by Type

  • 5.1. Oral Drug Delivery System
  • 5.2. Injection-based Drug Delivery System
  • 5.3. Inhalation/Pulmonary Drug Delivery System
  • 5.4. Transdermal Drug Delivery System
  • 5.5. Carrier-based Drug Delivery System
  • 5.6. Other Types

6. Global Advanced Drug Delivery Market by Application

  • 6.1. Cardiovascular Diseases
  • 6.2. Oncology
  • 6.3. Urology
  • 6.4. Diabetes
  • 6.5. Central Nervous System
  • 6.6. Ophthalmology
  • 6.7. Infections
  • 6.8. Other Applications

7. Global Advanced Drug Delivery Market by Technology

  • 7.1. Prodrug
  • 7.2. Implants and Intrauterine Devices
  • 7.3. Targeted Drug Delivery
  • 7.4. Polymeric Drug Delivery
  • 7.5. Other Technologies

8. Global Advanced Drug Delivery Market by Region 2021-2027

  • 8.1. North America
    • 8.1.1. North America Advanced Drug Delivery Market by Type
    • 8.1.2. North America Advanced Drug Delivery Market by Application
    • 8.1.3. North America Advanced Drug Delivery Market by Technology
    • 8.1.4. North America Advanced Drug Delivery Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Advanced Drug Delivery Market by Type
    • 8.2.2. Europe Advanced Drug Delivery Market by Application
    • 8.2.3. Europe Advanced Drug Delivery Market by Technology
    • 8.2.4. Europe Advanced Drug Delivery Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Advanced Drug Delivery Market by Type
    • 8.3.2. Asia-Pacific Advanced Drug Delivery Market by Application
    • 8.3.3. Asia-Pacific Advanced Drug Delivery Market by Technology
    • 8.3.4. Asia-Pacific Advanced Drug Delivery Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Advanced Drug Delivery Market by Type
    • 8.4.2. RoW Advanced Drug Delivery Market by Application
    • 8.4.3. RoW Advanced Drug Delivery Market by Technology
    • 8.4.4. RoW Advanced Drug Delivery Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Advanced Drug Delivery Market
  • 9.2. Companies Profiles
    • 9.2.1. Pfizer Inc.
    • 9.2.2. AstraZeneca
    • 9.2.3. Becton, Dickinson and Company
    • 9.2.4. Abbott Laboratories
    • 9.2.5. Amgen Inc.
    • 9.2.6. Novartis AG
    • 9.2.7. Baxter International
    • 9.2.8. Bayer AG
    • 9.2.9. Medtronic
    • 9.2.10. Kindeva Drug Delivery L.P.